ITMCTR2000004096尚未招募1 期
Study on the Efficacy of Dingxuan Shuyu Decoction in Treating Hypertension Patients with Anxiety
Shuguang hospital0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 35 至 85(—)
- 性别
- All
入选标准
- •1. Patients with essential hypertension who have taken antihypertensive drugs or meet the diagnostic criteria for hypertension in the Chinese Guidelines for the Prevention and Treatment of Hypertension 2010: without antihypertensive drugs, measure blood pressure three times on different days, and systolic blood pressure >=140mmHg and /Or patients with diastolic blood pressure >=90 mmHg;
- •2. Patient mental health questionnaires conducted by professional psychologists, including GAD7 Anxiety Disorder Screening Scale and Hamilton Anxiety Scale (HAMA), GAD7 >=5 points and <=14 points and Hamilton Anxiety Scale (HAMA) >=7 points and Patients with <=21 points;
- •3. Meet the syndrome differentiation standard of Yin deficiency and Yang hyperactivity in TCM;
- •4. A history of oral anti-anxiety drugs but intolerance occurred;
- •5. Aged between 35 and 85 years old;
- •6. Stop taking other similar Chinese medicines and proprietary Chinese medicines during clinical observation;
- •7. Those who can cooperate in filling out questionnaires and surveys, and those who give informed consent.
排除标准
- •1. Acute myocardial infarction, unstable angina pectoris;
- •2. Patients with other heart diseases or severe cardiac insufficiency (NYHA cardiac function classification> Grade III);
- •3. Patients with poor control after standardized treatment of hypertension (blood pressure>170/105mmHg);
- •4. Severe arrhythmias, persistent rapid atrial fibrillation (average ventricular rate in a calm state> 100 beats/minute), atrial flutter (average ventricular rate in a calm state> 100 beats/minute), frequent ventricular early (24 hours ventricular Premature beats> 7200) or ventricular tachycardia;
- •5. Patients with severe primary diseases such as brain, liver, kidney, hematopoietic system;
- •6. Diabetic patients with unstable blood sugar control and diabetic ketoacidosis;
- •7. Patients with serious mental illnesses, such as hallucinations, delusions, panic and suicidal behaviors; Generalized Anxiety Disorder Scale (GAD-7 Scale)>14 points and Hamilton Anxiety Scale (HAMA)>21 points;
- •8. Women during pregnancy or lactation, as well as men and women of childbearing age who have recent birth plans;
- •9. Allergic patients who are allergic to the test drug.
研究者
相似试验
招募中
1 期
Clinical study of Shenshi Qianghuo Dihuang Decoction in the treatment of Rheumatoid arthritis from the perspective of ''7+1''Rheumatoid arthritisITMCTR2000003850Shanghai Traditional Chinese Medicine Hospital
尚未招募
不适用
Study on the efficacy of Taohong Siwu Decoction in treating Hepatitis B related fibrosis and its correlation with iron metabolismHepatitis B related fibrosisITMCTR2100004426The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
招募中
1 期
Clinical effects of Shou-Wu Jiang-Qi Decoction combined acupuncture on in the treatment of Polycystic Ovarian Syndrome with kidney deficiency, phlegm and blood stasis nessITMCTR1900002826Zhang-Jia-Gang TCM Hospital Affiliated to Nanjing University of Chinese Medicine
尚未招募
1 期
Clinical Observation of Ziyinliangxue Decoction Combined with Moxibustion in Treating Chronic Glomerulonephritis with Deficiency of Qi and YiITMCTR2000003646Shanghai Traditional Chinese Medicine Hospital
尚未招募
1 期
Clinical study of Dachaihu decoction in promoting gastrointestinal function recovery after gastrointestinal tumor surgeryGastrointestinal tumorsITMCTR2200005722Shanxi Provincial Hospital of Traditional Chinese Medicine (Shanxi Provincial Institute of Traditional Chinese Medicine)
